BIOVIEW LTD.

BioView is a leading developer and manufacturer of automated cell imaging and analysis solutions for cytogenetics, oncology, and pathology laboratories. With nearly two decades of expertise, BioView specializes in diagnostic automation technology, particularly automated FISH (Fluorescence In Situ Hybridization) imaging and analysis. The company's comprehensive product portfolio includes the Cytogenetics Suite featuring automated karyotyping and FISH imaging platforms, as well as scanning systems ranging from manual workstations to fully automated loaders. BioView offers FDA-cleared and CE-marked applications for diverse diagnostics including hematology, prenatal testing, circulating tumor cell detection, and oncology applications. The company provides web-based analysis tools enabling case analysis and reporting from any location without software installation. BioView's systems are designed to enhance laboratory efficiency, accuracy, and standardization across diverse clinical and research workflows.